1. Home
  2. DMLP vs INSP Comparison

DMLP vs INSP Comparison

Compare DMLP & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DMLP

Dorchester Minerals L.P.

N/A

Current Price

$30.39

Market Cap

1.5B

Sector

Energy

ML Signal

N/A

Logo Inspire Medical Systems Inc.

INSP

Inspire Medical Systems Inc.

N/A

Current Price

$74.04

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DMLP
INSP
Founded
2003
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2002
2018

Fundamental Metrics

Financial Performance
Metric
DMLP
INSP
Price
$30.39
$74.04
Analyst Decision
Buy
Analyst Count
0
16
Target Price
N/A
$94.00
AVG Volume (30 Days)
98.1K
554.2K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
9.98%
N/A
EPS Growth
N/A
179.43
EPS
1.20
N/A
Revenue
$152,832,000.00
$82,050,000.00
Revenue This Year
N/A
$8.02
Revenue Next Year
N/A
$8.11
P/E Ratio
$25.34
N/A
Revenue Growth
N/A
62.18
52 Week Low
$20.85
$38.91
52 Week High
$29.74
$147.03

Technical Indicators

Market Signals
Indicator
DMLP
INSP
Relative Strength Index (RSI) 77.37 78.16
Support Level $25.19 $53.39
Resistance Level N/A $86.00
Average True Range (ATR) 0.45 3.12
MACD 0.05 1.05
Stochastic Oscillator 94.04 95.49

Price Performance

Historical Comparison
DMLP
INSP

About DMLP Dorchester Minerals L.P.

Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits, and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonuses, and others.

About INSP Inspire Medical Systems Inc.

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.

Share on Social Networks: